We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

219 hedge funds and large institutions have $1.58B invested in Select Medical in 2020 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 83 increasing their positions, 63 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 63

11% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 38

3.3% more ownership

Funds ownership: 141.77%145.06% (+3.3%)

1% more funds holding

Funds holding: 217219 (+2)

34% less capital invested

Capital invested by funds: $2.39B → $1.58B (-$817M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

61% less call options, than puts

Call options by funds: $868K | Put options by funds: $2.25M

Holders
219
Holders Change
+2
Holders Change %
+0.92%
% of All Funds
4.82%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
42
Increased
83
Reduced
63
Closed
38
Calls
$868K
Puts
$2.25M
Net Calls
-$1.38M
Net Calls Change
-$13.6M
Name Holding Trade Value Shares
Change
Change in
Stake
BC
151
Burney Company
Virginia
$216K
GIA
152
Gladstone Institutional Advisory
Florida
$206K +$302K +25,453 New
CGH
153
Crossmark Global Holdings
Texas
$205K
PTC
154
Petrus Trust Company
Texas
$200K -$55.4K -4,662 -16%
OR
155
Olympiad Research
Connecticut
$197K +$289K +24,334 New
MYIA
156
Mount Yale Investment Advisors
Colorado
$194K +$71.5K +6,014 +33%
MFG
157
Magnus Financial Group
New York
$193K +$87.7K +7,381 +45%
RJA
158
Raymond James & Associates
Florida
$191K -$689 -58 -0.2%
Capital Fund Management (CFM)
159
Capital Fund Management (CFM)
France
$189K +$278K +23,432 New
HMS
160
Hanseatic Management Services
New Mexico
$181K -$34.8K -2,929 -12%
Qube Research & Technologies (QRT)
161
Qube Research & Technologies (QRT)
United Kingdom
$180K -$256K -21,526 -49%
IA
162
IndexIQ Advisors
New York
$179K +$263K +22,129 New
Zurich Cantonal Bank
163
Zurich Cantonal Bank
Switzerland
$166K +$82.8K +6,971 +51%
CIBC Asset Management
164
CIBC Asset Management
Ontario, Canada
$154K
AIP
165
Ameritas Investment Partners
Nebraska
$148K +$6.21K +523 +3%
NICM
166
Neo Ivy Capital Management
New York
$147K +$216K +18,144 New
OSAM
167
O'Shaughnessy Asset Management
Connecticut
$143K +$70.3K +5,920 +50%
UFF
168
USA Financial Formulas
Michigan
$133K +$196K +16,505 New
SGAM
169
Smith Group Asset Management
Texas
$130K -$440 -37 -0.2%
UBS Group
170
UBS Group
Switzerland
$117K +$128K +10,748 +286%
PNC Financial Services Group
171
PNC Financial Services Group
Pennsylvania
$107K +$19.3K +1,626 +14%
NIT
172
NumerixS Investment Technologies
British Columbia, Canada
$92K +$136K +11,424 New
GT
173
Glenmede Trust
Pennsylvania
$90K
MAM
174
Meeder Asset Management
Ohio
$82K +$109K +9,189 +946%
MOACM
175
Mutual of America Capital Management
New York
$71K +$20K +1,687 +24%

SEM Hedge Fund Activity: Q1 2020 in Review

219 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q1 2020, worth a combined $1.58B — down 34% from $2.39B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new SEM positions and 38 closed out — a net gain of 4 holders — while 83 added to existing stakes and 63 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $22.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $48.6M.

  • 219 institutional investors held Select Medical (SEM) as of Q1 2020, up from 217 in Q4 2019.
  • Funds reported $1.58B of Select Medical stock for Q1 2020, down 34% quarter-over-quarter.
  • 42 funds opened new Select Medical positions in Q1 2020 and 38 closed out, a net change of +4 holders.
  • The largest Select Medical buyer in Q1 2020 was Victory Capital Management, an estimated $22.5M added.
  • The largest Select Medical seller in Q1 2020 was T. Rowe Price Associates, an estimated $48.6M sold.

Based on aggregated 13F filings for Q1 2020.